Abstract
Green tea is now known to be the most effective beverage for cancer prevention, and evidence of this was recently extended to clinical applications. This paper briefly reviews several topics with regard to the development of our study on cancer prevention with green tea, and proposes a strategy for two-stages of cancer prevention with green tea. The topics are : 1) introduction of our initial work on (-)-epigallocatechin gallate (EGCG), the main constituent of Japanese green tea; 2) cancer preventive effects of EGCG and green tea extract, the lyophilized form of green tea infusion; 3) bioavailability of 3H-EGCG in mice; 4) delay of cancer onset by drinking 10 Japanese-size cups of green tea per day; 5) a prototype study for developing green tea beverage supplemented with green tea tablets by 102 healthy volunteers; 6) cancer prevention before cancer onset for the general population and high risk groups; 7) cancer prevention for patients following cancer treatment; 8) an example of a clinical trial looking toward prevention of cancer recurrence in the liver; and 9) possible prevention of human lung cancer. Considering all the above, green tea is a multi-, non-toxic cancer preventive for humans: It is natures remedy.
Keywords: green tea, egcg, 10 japanese-size cups, general population, cancer patients
Current Cancer Therapy Reviews
Title: Cancer Prevention with Green Tea Polyphenols for the General Population, and for Patients Following Cancer Treatment
Volume: 1 Issue: 1
Author(s): Hirota Fujiki, Masami Suganuma, Satoru Matsuyama and Kohji Miyazaki
Affiliation:
Keywords: green tea, egcg, 10 japanese-size cups, general population, cancer patients
Abstract: Green tea is now known to be the most effective beverage for cancer prevention, and evidence of this was recently extended to clinical applications. This paper briefly reviews several topics with regard to the development of our study on cancer prevention with green tea, and proposes a strategy for two-stages of cancer prevention with green tea. The topics are : 1) introduction of our initial work on (-)-epigallocatechin gallate (EGCG), the main constituent of Japanese green tea; 2) cancer preventive effects of EGCG and green tea extract, the lyophilized form of green tea infusion; 3) bioavailability of 3H-EGCG in mice; 4) delay of cancer onset by drinking 10 Japanese-size cups of green tea per day; 5) a prototype study for developing green tea beverage supplemented with green tea tablets by 102 healthy volunteers; 6) cancer prevention before cancer onset for the general population and high risk groups; 7) cancer prevention for patients following cancer treatment; 8) an example of a clinical trial looking toward prevention of cancer recurrence in the liver; and 9) possible prevention of human lung cancer. Considering all the above, green tea is a multi-, non-toxic cancer preventive for humans: It is natures remedy.
Export Options
About this article
Cite this article as:
Fujiki Hirota, Suganuma Masami, Matsuyama Satoru and Miyazaki Kohji, Cancer Prevention with Green Tea Polyphenols for the General Population, and for Patients Following Cancer Treatment, Current Cancer Therapy Reviews 2005; 1 (1) . https://dx.doi.org/10.2174/1573394052952474
DOI https://dx.doi.org/10.2174/1573394052952474 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
AMPK Regulation of Glucose, Lipid and Protein Metabolism: Mechanisms and Nutritional Significance
Current Protein & Peptide Science The Ubiquitin-Proteasome System (UPS) and the Mechanism of Action of Bortezomib
Current Pharmaceutical Design Alternative Polyadenylation and Its Impact on Cellular Processes
MicroRNA Atypical PKCι as Target for Glioblastoma Therapy
Current Cancer Drug Targets Anti-tumor Therapeutic Molecules that Target the Programmed Cell Death Machinery
Mini-Reviews in Medicinal Chemistry The Biology of TRAIL and the Role of TRAIL-Based Therapeutics in Infectious Diseases
Anti-Infective Agents in Medicinal Chemistry Impact of New Technologies on Pharmacogenomics
Current Pharmacogenomics and Personalized Medicine Potential Role of MEK Inhibition in Treating Patients with Colorectal Cancer
Current Cancer Therapy Reviews Brain-metastatic Breast Cancer: Clinical Considerations and Pharmacological Approaches
Anti-Cancer Agents in Medicinal Chemistry Molecular Modeling and Virtual Screening of DNA Methyltransferase Inhibitors
Current Pharmaceutical Design Editorial [Hot Topic:Targeted Therapeutics – From Chemical Structures to Diagnostic and Therapeutic Agents(Executive Editor: Christine Armbruster)]
Current Pharmaceutical Design Recent Trends of Chalcones Potentialities as Antiproliferative and Antiresistance Agents
Anti-Cancer Agents in Medicinal Chemistry Targeting Mitochondrial Citrate Transport in Breast Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Recent Progress in the Synthesis of Naturally Occurring Triterpenoid Saponins
Mini-Reviews in Organic Chemistry The Adrenergic System in Gastrointestinal Cancers
Current Cancer Therapy Reviews Formulation Optimization of Etoposide Loaded PLGA Nanoparticles by Double Factorial Design and their Evaluation
Current Drug Delivery Combining Quantum-Behaved PSO and K2 Algorithm for Enhancing Gene Network Construction
Current Bioinformatics Drug Eluting Stents and Beyond
Current Pharmaceutical Design AMPK as a New Attractive Therapeutic Target for Disease Prevention: The Role of Dietary Compounds AMPK and Disease Prevention
Current Drug Targets Evaluation of Pregabalin Therapy in Peripheral Neuropathy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)